Reports for FRESENIUS KABI CANADA LTD
Company Name FRESENIUS KABI CANADA LTD |
||
|---|---|---|
Totals |
||
Shortage reports |
341 |
|
| Actual shortage: | 5 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (1%) | |
| Resolved: | 331 (97%) | |
Discontinuation Reports |
2 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
51 (15%) |
|
Overdue reports |
3 (60%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2021-03-26 | 2022-04-13 | 136448 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2021-03-26 | 2022-01-31 | 136445 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2020-12-09 | 2021-01-22 | 129882 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2020-04-07 | 2020-04-25 | 111239 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2019-07-26 | 2020-01-16 | 90057 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10 mg/mL | Solution | Resolved | 2018-06-06 | 2019-03-01 | 51691 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10 mg/mL | Solution | Resolved | 2018-06-06 | 2019-03-01 | 51686 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 5 mg/mL | Solution | Resolved | 2018-06-06 | 2019-09-13 | 51683 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2 mg/mL | Solution | Resolved | 2018-06-06 | 2018-10-02 | 51680 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2mg/mL | Solution | Resolved | 2018-06-06 | 2018-10-02 | 51677 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-03-26 | 2021-04-16 | 136455 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2023-01-16 | 2023-11-17 | 181157 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2023-01-16 | 2023-04-04 | 181154 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 5MG | SOLUTION | Resolved | 2021-03-26 | 2021-04-16 | 136451 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 5MG | SOLUTION | Resolved | 2022-03-01 | 2022-10-02 | 155808 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 5MG | SOLUTION | Resolved | 2024-08-16 | 2024-10-17 | 235457 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2022-04-13 | 2022-08-29 | 158792 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2022-04-13 | 2022-09-01 | 158789 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-10-21 | 2021-12-31 | 147731 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-03-26 | 2021-04-16 | 136460 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Discontinued | 2024-08-13 | 2024-08-20 | 235203 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Discontinued | 2024-10-03 | 2024-10-03 | 239180 |
Showing 1 to 2 of 2